1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDeadline is May 26, 2026 at 11:59 PM EAT, matching stored deadline.
The True Colours Trust Palliative Care Development in Africa Programme for Small Grants is sponsored by The True Colours Trust. This program supports excellent local organizations and projects in Africa that work with disabled children and their families, adhering to the WHO definition of palliative care.
Get alerted about grants like this
Save a search for “The True Colours Trust” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
How to Apply – Africa Small Grants – The True Colours Trust The latest round of the Africa Small Grants programme for Palliative Care Development in Africa is now open. The True Colours Tr u s t Palliative Care Development in Africa Programme for Small Grants call for applications is now open. We look forward to receiving applicants’ proposals until 26th May 2026, 23:59 EAT .
All project proposals must comply to the application guidelines and should be submitted using the application form and Budget templates provided in the link below. Download and read the guidelines document to ensure your project is in line with the grant scheme priority areas. Download the application form and accompanying tips document.
Ensure you have completed all items on the checklist and that all necessary accompanying documents are provided. Submit the completed form and accompanying documents via email to truecolourssmallgrants@africanpalliativecare. org The African Palliative Care Association shall organize a briefing session for potential applicants who require further guidance on the application process.
If you would like to receive the link and login for the call, or should you require additional support or information while developing the proposals you can contact the Programme Officer Small Grants at APCA by email at: truecolourssmallgrants@africanpalliativecare. org . Please note that we receive a large number of applications and some applications will therefore be unsuccessful.
We will endeavour to communicate the trustees’ decision to all applicants within 8 weeks of the closing date. For support with your application Please contact the Small Grants Officer, David Byaruhanga, at APCA by telephone +256 312 264978 or email at: truecolourssmallgrants@africanpalliativecare. org .
Applications are accepted twice a year. What to expect if you are successful in applying for a grant If you are successful in applying for a grant, you will be notified by APCA who will send you a grant approval letter and agreement outlining the terms and conditions of the grant.
Once the grant has been paid to your organisation, you will be required to report on the progress of the grant on a quarterly basis and to provide a financial report on how the grant was used. This will be explained in your agreement. What to do if your application is not successful If your application is not successful, you will receive a letter of regret from APCA.
Please feel free to ask for feedback on your application. Failure to succeed on one grant round does not stop you from applying for the next round. Schedule of Programme Activities Each year, two rounds of small grants are awarded.
These rounds take place in the spring (approx. March - May) and the autumn (approx. September - November).
Based on current listing details, eligibility includes: Applicants must ensure their project is in line with the grant scheme priority areas. Stored record indicates registered hospices and palliative care providers based and managed in Africa. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to GBP £5,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is May 26, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.